We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Sponsor content
2 result(s) found, displaying 1 to 2
-
Australian public assessment report (AusPar)Orserdu monotherapy is indicated for the treatment of postmenopausal women and men with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer with an activating ESR1 mutation.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Fentanyl citrate